Refinement of genetic localization of the Alstrom syndrome on chromosome 2p12-13 by linkage analysis in a North African family

被引:28
作者
Macari, F
Lautier, C
Girardet, A
Dadoun, F
Darmon, P
Dutour, A
Renard, E
Bouvagnet, P
Claustres, M
Oliver, C
Grigorescu, F
机构
[1] IURC Mol Endocrinol, F-34093 Montpellier 5, France
[2] CNRS, CRBM, ERS 155, F-34033 Montpellier, France
[3] Hop Nord, Dept Endocrinol, F-13915 Marseille, France
关键词
D O I
10.1007/s004390050887
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Alstrom syndrome is a rare autosomal recessive disorder characterized by retinal pigment degeneration, neurogenic deafness, infantile obesity, hyperlipidemia, and non-insulin-dependent diabetes mellitus. While the disease-related gene remains unknown, studies of the genetic isolate of French Acadians provisionally locate the Alstrom syndrome on chromosome 2p12-13 within a 14.9-cM interval. To confirm this finding in another ethnic population and refine the candidate region we investigated by linkage analysis a consanguineous family of North African origin, in which three of seven siblings displayed all major neurological and metabolic features of Alstrom syndrome. Genotyping was performed on an ABI377 DNA automatic sequencer and LOD scores were obtained with the Fastlink program. Five markers previously investigated in French Acadians confirmed the involvement of the candidate region, although pairwise LOD scores were of poor significance (Z(max)=2.9). To further confirm homogeneity and refine the candidate region, 20 additional markers were investigated. Haplotype analysis and allele segregation revealed that affected children shared a single haplotype and were homozygous for the eight most centromeric markers (D2S291-D2S2114), over a 6.1-cM interval. Significative multipoint LOD scores (Z(max)=3.96) were obtained between markers D2S2110/145 and D2S286. Two clusters of known genes are present in this refined region of chromosome 2p, the most attractive candidate being the hexokinase II gene. However, except for several known polymorphisms, no mutations were detected in the coding region of this gene. In conclusion, the location of Alstrom syndrome on chromosome 2p 12-13 is confirmed, reducing the genetic interval to 6.-cM.
引用
收藏
页码:658 / 661
页数:4
相关论文
共 13 条
[1]  
Alstrom C.H., 1959, ACTA PSYCH NEUROL SC, V129, P1
[2]   Genetic and physical mapping at the limb-girdle muscular dystrophy locus (LCMD2B) on chromosome 2p [J].
Bashir, R ;
Keers, S ;
Strachan, T ;
PassosBueno, R ;
Zatz, M ;
Weissenbach, J ;
LePaslier, D ;
Meisler, M ;
Bushby, K .
GENOMICS, 1996, 33 (01) :46-52
[3]   Homozygosity mapping of Alstrom syndrome to chromosome 2p [J].
Collin, GB ;
Marshall, JD ;
Cardon, LR ;
Nishina, PM .
HUMAN MOLECULAR GENETICS, 1997, 6 (02) :213-219
[4]  
COTTINGHAM RW, 1993, AM J HUM GENET, V53, P252
[5]   A comprehensive genetic map of the human genome based on 5,264 microsatellites [J].
Dib, C ;
Faure, S ;
Fizames, C ;
Samson, D ;
Drouot, N ;
Vignal, A ;
Millasseau, P ;
Marc, S ;
Hazan, J ;
Seboun, E ;
Lathrop, M ;
Gyapay, G ;
Morissette, J ;
Weissenbach, J .
NATURE, 1996, 380 (6570) :152-154
[6]   IDENTIFICATION OF 4 AMINO-ACID SUBSTITUTIONS IN HEXOKINASE-II AND STUDIES OF RELATIONSHIPS TO NIDDM, GLUCOSE EFFECTIVENESS, AND INSULIN SENSITIVITY [J].
ECHWALD, SM ;
BJORBAEK, C ;
HANSEN, T ;
CLAUSEN, JO ;
VESTERGAARD, H ;
ZIERATH, JR ;
PRINTZ, RL ;
GRANNER, DK ;
PEDERSEN, O .
DIABETES, 1995, 44 (03) :347-353
[7]  
GHANEM N, 1988, EXP CLIN IMMUNOGENET, V5, P186
[8]   ALSTROM SYNDROME - REPORT OF 3 CASES WITH FURTHER DELINEATION OF CLINICAL, PATHOPHYSIOLOGICAL, AND GENETIC ASPECTS OF DISORDER [J].
GOLDSTEIN, JL ;
FIALKOW, PJ .
MEDICINE, 1973, 52 (01) :53-71
[9]   MULTIPLE FORMS OF HEXOKINASE IN RAT - TISSUE DISTRIBUTION AGE DEPENDENCY AND PROPERTIES [J].
KATZEN, HM ;
SCHIMKE, RT .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1965, 54 (04) :1218-&
[10]   SYNDROME OF LAURENCE-MOON-BARDET-BIEDL AND ALLIED DISEASES IN SWITZERLAND . CLINICAL, GENETIC AND EPIDEMIOLOGICAL STUDIES [J].
KLEIN, D ;
AMMANN, F .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1969, 9 (03) :479-&